Pharmacy locations owned and operated by Walgreens Company
| Rank | Pharmacy chain | Pharmacists |
|---|---|---|
| 1 | Walgreens Company | 48,986 |
| 2 | CVS Health | 31,235 |
| 3 | Walmart | 15,369 |
| 4 | Rite Aid Corp | 10,869 |
Nog 21 rijen
What is the largest pharmacy in the world?
According to research that was carried out on the 11th of December in 2017, Chongqing Tongjunge Drugstores Co. Ltd, which is based in China, is the largest chemist/pharmacy shop chain in terms of retail current, and it has 12,000 outlets in 2017. CVS Pharmacy in the United States is the second biggest network of chemists and pharmacies, with 9,706 locations.
What is the #1 prescribed drug?
The 300 Most Prevalent Drugs in 2019
| Rank | Drug Name | Total Prescriptions (2019) |
|---|---|---|
| 1 | Atorvastatin | 112,104,359 |
| 2 | Levothyroxine | 102,595,103 |
| 3 | Lisinopril | 91,862,708 |
| 4 | Metformin | 85,739,443 |
Is CVS or Walgreens more successful?
The sixth of January in Mill Valley, California: This photograph was taken on January 6, 2022 in Mill Valley, California, and shows the front of a Walgreens business. Walgreens announced earnings for the first quarter that were higher than what analysts had expected, and the company’s revenues were $33.9 billion, compared to a loss of $391 million in the same period last year.
(Image courtesy of Getty Images and Justin Sullivan) Images obtained from Getty Even though CVS Health stock (NYSE: CVS) has a P/S ratio of 0.5x and Walgreens Boots Alliance stock (NYSE: WBA) has a P/S ratio of 0.3x, we believe that investing in CVS Health stock (NYSE: CVS) is a better choice than investing in Walgreens Boots Alliance stock (NYSE: WBA) right now.
Even when we take into account the price to earnings before interest and taxes (P/EBIT) ratio, we see that CVS is selling at a significantly higher multiple than Walgreens, which is 8.5x. Although both firms reported an increase in revenue over the course of the previous year as a result of Covid-19 testing and the administration of vaccines, Walgreens has seen growth that has been slightly stronger than its competitor.
- Comparing the two companies’ stock returns over the past year reveals that CVS’s growth of 50% is far superior to WBA’s return of -1%.
- Although it is likely that both companies will experience a slowdown in sales growth in the post-pandemic period as a result of a lower contribution from Covid-19 testing and vaccine administration, the stock price of CVS has been supported by the company’s plans to raise dividends and share repurchases.
However, there are further factors to consider, and based on the information presented in the following sections, we predict that CVS will provide superior returns over the course of the next three years. In an interactive dashboard study, we evaluate a variety of parameters including historical revenue growth, returns, and valuation multiple.
- When comparing Walgreens with CVS Health: Which Stock Is A Better Bet? The following is a summary of several aspects of the analysis.1.
- The increase in revenue that CVS Health has seen has been stronger In the most recent quarters, both firms have been successful in increasing their sales, although Walgreens has seen a somewhat higher revenue increase than its competitor.
When looking at sales over a longer period of time, CVS’s revenues have increased from $185 billion in 2017 to $285 billion over the last twelve months, whilst Walgreens’ revenues have increased from $118 billion to $135 billion over the same period of time.
The increased demand for Covid-19 testing as well as vaccination delivery contributed, at least in part, to the revenue rise seen by both of the firms. Our Walgreens Revenue and CVS Health Revenue dashboards offer a deeper understanding of the sales made by the firms. Now, Walgreens’ revenue growth of 9% over the previous twelve month period is somewhat greater than CVS Health’s growth of 7%, given an enhanced contribution from its foreign company.
This is because Walgreens has been able to raise its market share in overseas markets. If we look at a little longer time frame, however, we see that CVS has outperformed Walgreens. Over the past three years, CVS’s revenue has grown at a compound annual growth rate of 14%, while Walgreens’ revenue has grown at a rate of 0.5%.
It is important to note that CVS’s acquisition of Aetna before the end of 2018 helped to boost the company’s revenue. It is anticipated that both businesses would experience a reduction in their contribution from vaccine administration in the coming years. In the next three years, it is anticipated that CVS’s revenue will expand at a quicker pace compared to Walgreens’ revenue growth.
According to a study conducted by Trefis Machine Learning, the table that follows provides a summary of our revenue forecast for the two firms over the next three years. This forecast indicates that CVS will have a CAGR of 11%, while Walgreens will only have a CAGR of 2%.
- Be aware that when we anticipate future revenues, we use different methods for businesses that have been badly impacted by Covid, businesses that have not been influenced by Covid, and businesses that have been favourably impacted by Covid.
- In the case of businesses that were adversely affected by Covid, we take into account the quarterly revenue recovery trajectory in order to project a recovery to the revenue run rate that existed prior to the implementation of Covid.
After the recovery point, we apply the average annual growth that was seen in the three years prior to the implementation of Covid in order to simulate a return to normal conditions. We take into account the average yearly growth prior to Covid, with a particular weight placed on growth during Covid and over the course of the previous year, for businesses that reported positive revenue growth throughout the course of Covid.
WBA and CVS Trefis in Terms of Their Anticipated Rates of Revenue Growth 2. Walgreens Generates Greater Profits With No Additional Danger When compared to CVS’s operating margin of 2.5%, Walgreens’ operating margin of 3.7% over the past twelve months represents a modest improvement. In addition, if we were to look at the recent rise in margins, we would see that Walgreens has been doing better than CVS.
10 Biggest Drug Companies in USA
The change in margins over the previous twelve months and the last three years was 1% for Walgreens, but the change was -2.5% for CVS. Over the course of the last few years, the operating margins of both businesses were quite stable. During the same time period, Walgreens’ operating margin fell from 4.0% in 2019 to 1.8% at the present time, while CVS’ operating margin fell from levels of 4.6% to 4.0%.
More information may be found on the dashboards pertaining to Walgreens Operating Income and CVS Health Operating Income. When it comes to the potential for financial loss, both are comparable. The ratio of debt to equity for Walgreens is 32%, which is lower than the ratio of debt to equity for CVS, which is 40%, and the ratio of cash to assets for Walgreens is 4%, which is lower than the ratio of cash to assets for CVS, which is 6%.
This indicates that Walgreens has a better debt position, while CVS has a better cash position.3. The Bottom Line of Everything We can see that over the course of the past three years, CVS has shown a higher rate of revenue increase than Walgreens has.
In comparison to Walgreens, there is no additional financial risk associated with it. However, the latter option is more profitable, and it is now being offered at a valuation that is more favorable. Now, looking at future possibilities, using P/S as a benchmark, due to substantial volatility in P/E and P/EBIT, we feel that the best pick right now is CVS rather than Walgreens.
The following table provides a summary of our revenue and return expectations for Walgreens and CVS over the next three years. It indicates an expected return of 18% for CVS over this period compared to just 5% expected return for WBA stock, which suggests that investors would be better off purchasing CVS rather than WBA.
- This conclusion is based on an analysis conducted by Trefis Machine Learning – Walgreens vs.
- CVS Health – which also provides more details on how we arrive at these numbers. WBA vs.
- CVS Trefis Is the Anticipated Payoff Even if it is anticipated that CVS stock would outperform WBA in the years to come, it is still essential to examine how CVS’ competitors perform on key measures.
Peer Comparisons is where you will find further helpful comparisons for organizations in a wide variety of sectors. What if, rather than that, you’re seeking for a portfolio that’s more diversified? This is a high-quality portfolio that has outperformed the market on a steady basis ever since the year 2016 came to a close.
Which one is better CVS or Walgreens?
When it comes to sales, CVS is a step ahead of Walgreens. We examined the bargains that Krazy Coupon Lady offers at CVS and Walgreens for a period of one month and discovered that CVS offers greater savings on average than Walgreens does. For instance, CVS saved customers an average of 69% in the areas of “beauty” and “hair care,” whereas Walgreens’ customers saved an average of just 60%.